Guardado en:
| Autores principales: | Xi, Nan Miles, Jin, Man Mandy, Wang, Lin, Huang, Xin |
|---|---|
| Formato: | Preprint |
| Publicado: |
2025
|
| Materias: | |
| Acceso en línea: | https://arxiv.org/abs/2506.03086 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
A Two-Step Test to Identify Zero-Inflated Biomarkers in Early-Phase Clinical Trials
por: Xi, Nan Miles, et al.
Publicado: (2025)
por: Xi, Nan Miles, et al.
Publicado: (2025)
Bayesian Optimization for Personalized Dose-Finding Trials with Combination Therapies
por: Willard, James, et al.
Publicado: (2023)
por: Willard, James, et al.
Publicado: (2023)
An Efficient Approach to Design Bayesian Platform Trials
por: Hagar, Luke, et al.
Publicado: (2025)
por: Hagar, Luke, et al.
Publicado: (2025)
Principles of Conditionality and Layering of Error Rates with Application to Platform Trials
por: Cui, Xinping, et al.
Publicado: (2023)
por: Cui, Xinping, et al.
Publicado: (2023)
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
por: Chen, Yuxuan, et al.
Publicado: (2026)
por: Chen, Yuxuan, et al.
Publicado: (2026)
From Estimands to Robust Inference of Treatment Effects in Platform Trials
por: Qian, Yuhan, et al.
Publicado: (2024)
por: Qian, Yuhan, et al.
Publicado: (2024)
Causal Survival Analysis in Platform Trials with Non-Concurrent Controls
por: D'Alessandro, Antonio, et al.
Publicado: (2026)
por: D'Alessandro, Antonio, et al.
Publicado: (2026)
A Unified Approach to Covariate Adjustment for Survival Endpoints in Randomized Clinical Trials
por: Zhang, Zhiwei, et al.
Publicado: (2025)
por: Zhang, Zhiwei, et al.
Publicado: (2025)
Generalized Tree-Informed Mixed Model Regression
por: Allis, Jeremiah, et al.
Publicado: (2025)
por: Allis, Jeremiah, et al.
Publicado: (2025)
Comparing HIV Vaccine Immunogenicity across Trials with Different Populations and Study Designs
por: Jin, Yutong, et al.
Publicado: (2024)
por: Jin, Yutong, et al.
Publicado: (2024)
Combining experimental and observational data through a power likelihood
por: Lin, Xi, et al.
Publicado: (2023)
por: Lin, Xi, et al.
Publicado: (2023)
Active-Controlled Trial Design for HIV Prevention Trials with a Counterfactual Placebo
por: Gao, Fei, et al.
Publicado: (2024)
por: Gao, Fei, et al.
Publicado: (2024)
An Integrated and Coherent Framework for Point Estimation and Hypothesis Testing with Concurrent Controls in Platform Trials
por: Zhan, Tianyu, et al.
Publicado: (2025)
por: Zhan, Tianyu, et al.
Publicado: (2025)
Robust and Data-Adaptive Integration of Nonconcurrent Data in Platform Trials via Gaussian Processes
por: Qian, Yuhan, et al.
Publicado: (2026)
por: Qian, Yuhan, et al.
Publicado: (2026)
Studying Optimal Designs for Multivariate Crossover Trials
por: Niphadkar, Shubham, et al.
Publicado: (2025)
por: Niphadkar, Shubham, et al.
Publicado: (2025)
Design of Bayesian Clinical Trials with Clustered Data
por: Hagar, Luke, et al.
Publicado: (2025)
por: Hagar, Luke, et al.
Publicado: (2025)
The Win Ratio at the Design Stage of Clinical Trials
por: Kronthaler, David, et al.
Publicado: (2025)
por: Kronthaler, David, et al.
Publicado: (2025)
Bayesian Variable Selection on Small Sample Trial Data via Adaptive Posterior-Informed Shrinkage Prior
por: Kong, Lingxuan, et al.
Publicado: (2025)
por: Kong, Lingxuan, et al.
Publicado: (2025)
Bayesian Optimization for Identification of Optimal Biological Dose Combinations in Personalized Dose-Finding Trials
por: Willard, James, et al.
Publicado: (2024)
por: Willard, James, et al.
Publicado: (2024)
Externally Valid Policy Evaluation Combining Trial and Observational Data
por: Ek, Sofia, et al.
Publicado: (2023)
por: Ek, Sofia, et al.
Publicado: (2023)
Leveraging External Data for Testing Experimental Therapies with Biomarker Interactions in Randomized Clinical Trials
por: Ren, Boyu, et al.
Publicado: (2025)
por: Ren, Boyu, et al.
Publicado: (2025)
Policy-Aware Design of Large-Scale Factorial Experiments
por: Wen, Xin, et al.
Publicado: (2026)
por: Wen, Xin, et al.
Publicado: (2026)
Estimand framework and intercurrent events handling for clinical trials with time-to-event outcomes
por: Fang, Yixin, et al.
Publicado: (2025)
por: Fang, Yixin, et al.
Publicado: (2025)
A Targeted Learning Framework for Estimating Restricted Mean Survival Time Difference using Pseudo-observations
por: Jin, Man, et al.
Publicado: (2026)
por: Jin, Man, et al.
Publicado: (2026)
Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
por: Hua, Kaiyuan, et al.
Publicado: (2024)
por: Hua, Kaiyuan, et al.
Publicado: (2024)
Who's Winning? Clarifying Estimands Based on Win Statistics in Cluster Randomized Trials
por: Lee, Kenneth M., et al.
Publicado: (2026)
por: Lee, Kenneth M., et al.
Publicado: (2026)
Testing Elliptical Models in High Dimensions
por: Wang, Siyao, et al.
Publicado: (2024)
por: Wang, Siyao, et al.
Publicado: (2024)
ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
por: Wang, Shuqi, et al.
Publicado: (2024)
por: Wang, Shuqi, et al.
Publicado: (2024)
Bayesian Design and Analysis of Precision Trials with Partial Borrowing
por: Golchi, Shirin, et al.
Publicado: (2026)
por: Golchi, Shirin, et al.
Publicado: (2026)
Two-stage Adaptive Design Cluster Randomised Trials
por: Watson, Samuel I., et al.
Publicado: (2026)
por: Watson, Samuel I., et al.
Publicado: (2026)
Truncated Cauchy Combination Test: a Robust and Powerful P-value Combination Method with Arbitrary Correlations
por: Chen, Bo, et al.
Publicado: (2025)
por: Chen, Bo, et al.
Publicado: (2025)
Statistical Inference for Chi-square Statistics or F-Statistics Based on Multiple Imputation
por: Wang, Binhuan, et al.
Publicado: (2024)
por: Wang, Binhuan, et al.
Publicado: (2024)
Distribution-free screening of spatially variable genes in spatial transcriptomics
por: Wang, Changhu, et al.
Publicado: (2026)
por: Wang, Changhu, et al.
Publicado: (2026)
Cross-Balancing for Data-Informed Design and Efficient Analysis of Observational Studies
por: Jin, Ying, et al.
Publicado: (2025)
por: Jin, Ying, et al.
Publicado: (2025)
An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
por: Zehetmayer, Sonja, et al.
Publicado: (2026)
por: Zehetmayer, Sonja, et al.
Publicado: (2026)
Partial Ordering Bayesian Logistic Regression Model for Phase I Combination Trials and Computationally Efficient Approach to Operational Prior Specification
por: Chen, Weishi, et al.
Publicado: (2024)
por: Chen, Weishi, et al.
Publicado: (2024)
Simulation-Guided Planning of a Target Trial Emulated Cluster Randomized Trial for Mass Small-Quantity Lipid Nutrient Supplementation Combined with Expanded Program on Immunization in Rural Niger
por: Alam, Shomoita, et al.
Publicado: (2025)
por: Alam, Shomoita, et al.
Publicado: (2025)
A General Framework for Designing and Evaluating Active-Controlled Trials with Non-Inferiority Objectives
por: Olivas-Martinez, Antonio, et al.
Publicado: (2025)
por: Olivas-Martinez, Antonio, et al.
Publicado: (2025)
A Web-Based Application Leveraging Geospatial Information to Automate On-Farm Trial Design
por: Jha, Sneha, et al.
Publicado: (2025)
por: Jha, Sneha, et al.
Publicado: (2025)
Incertus.jl -- The Julia Lego Blocks for Randomized Clinical Trial Designs
por: Ryeznik, Yevgen, et al.
Publicado: (2024)
por: Ryeznik, Yevgen, et al.
Publicado: (2024)
Ejemplares similares
-
A Two-Step Test to Identify Zero-Inflated Biomarkers in Early-Phase Clinical Trials
por: Xi, Nan Miles, et al.
Publicado: (2025) -
Bayesian Optimization for Personalized Dose-Finding Trials with Combination Therapies
por: Willard, James, et al.
Publicado: (2023) -
An Efficient Approach to Design Bayesian Platform Trials
por: Hagar, Luke, et al.
Publicado: (2025) -
Principles of Conditionality and Layering of Error Rates with Application to Platform Trials
por: Cui, Xinping, et al.
Publicado: (2023) -
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
por: Chen, Yuxuan, et al.
Publicado: (2026)